Determinants of Cognitive Impairment After Acute Coronary Syndrome | MicrobiomeTrials← Back to trialsNCT00982176
Determinants of Cognitive Impairment After Acute Coronary Syndrome
CompletedNAINTERVENTIONAL
Trial Details
Start: 2009-09Est. Completion: 2012-12
Enrollment target: 49 participants Locations- CHU de Bordeaux, Bordeaux, France
- Hôpital Cardiologique du Haut-Lévêque (CEPTA), Pessac, France
Other microbiome trials you might be interested in
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Distress SyndromeSystemic Inflammatory Response Syndrome
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…
Alcalá de Henares, SpainEst. completion Oct 2, 2026
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Acute myocardial infarction is one of the leading causes of death in elderly patients, and the importance of lipid-lower…
Multiple LocationsEst. completion Jun 1, 2028
Heart Failure
Background:
More than 6.5 million people in the United States live with heart failure (HF), and more than a million new…
Falls Church, United StatesCompleted Apr 30, 2028